Dongcheng Pharmaceutical announced that its subsidiary 18F-LNC1007 injection has obtained a notice of approval for clinical trials of the drug.
东诚药业：下属公司18F-LNC1007注射液获得药物临床试验批准通知书
Dongcheng Pharmaceutical: Subsidiary company 18F-LNC1007 injection obtained drug clinical trial approval notice
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.